Boston, MANCT07095998Now EnrollingIRB Ready

Peripheral Neuropathy Due to Chemotherapy Clinical Trial in Boston, MA

Access cutting-edge peripheral neuropathy due to chemotherapy treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Ka-Wai Ho

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access peripheral neuropathy due to chemotherapy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related peripheral neuropathy due to chemotherapy treatment provided free

Apply for This Boston Location

Check if you qualify for this peripheral neuropathy due to chemotherapy clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Peripheral Neuropathy Due to Chemotherapy Study in Boston

This study aims to evaluate nerve excitability in participants with cisplatin-induced peripheral neuropathy (cis-PN) using threshold tracking nerve conduction studies (TTNCS). By assessing changes in nerve excitability parameters, the study seeks to enhance understanding of the pathophysiology of cis-PN and identify early markers of neurotoxicity in participants undergoing cisplatin-based chemotherapy.

Sponsor: Ka-Wai Ho

Who Can Participate

Inclusion Criteria

Adults age ≥ 18 who will begin cisplatin-based chemotherapy either alone or in combination with other agents that are not known to cause neuropathy.
Participants must have adequate hematologic parameters to allow chemotherapy.

Exclusion Criteria

Pre-existing peripheral neuropathy;
Family history of a genetic/familial neuropathy;
Any contraindication for treatment with cisplatin as determined by their primary oncologist;
Chemotherapy regimen combining cisplatin with another known chemotherapy agent that may cause peripheral neuropathy;
Patients with cardiac or spinal stimulating devices;
Women who are pregnant or breastfeeding;
Adults with impaired consent capacity as patients must be able to fill out questionnaires regarding their neuropathy symptoms;
Other medical conditions that in the opinion of the treating physician would make the protocol unreasonably hazardous for the patient;
Patients not considered to be able to comply with the protocol. Inclusion Criteria Cohort B:
Adults age ≥ 18 with a diagnosis of cis-PN.
The last dose of cisplatin must be ≥ 3 months prior to study enrollment. Patients who may have been previously enrolled in Cohort A of this study are eligible to participate in Cohort B if they continue to have cis-PN symptoms 3 months after completion of cisplatin therapy. Exclusion Criteria Cohort B:
Pre-existing peripheral neuropathy;
Family history of a genetic/familiar neuropathy;
History of cisplatin-based regimen combining cisplatin with another known chemotherapy agent that may cause peripheral neuropathy;
Patients with cardiac or spinal stimulating devices;
Women who are pregnant or breastfeeding;
Adults with impaired consent capacity as patients must be able to fill out questionnaires regarding their neuropathy symptoms;
Other medical conditions that in the opinion of the treating physician would make the protocol unreasonably hazardous for the patient;
Patients not considered to be able to comply with the protocol.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT07095998) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Peripheral Neuropathy Due to Chemotherapy Treatment Options in Boston, MA

If you're searching for peripheral neuropathy due to chemotherapy treatment options in Boston, MA, this clinical trial (NCT07095998) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced peripheral neuropathy due to chemotherapy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all peripheral neuropathy due to chemotherapy clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Boston, MA

See all pulmonary embolism clinical trials recruiting in Boston — not just this study.

Browse Pulmonary Embolism Trials in Boston →

Browse More Trials by Condition

Pulmonary Embolism TrialsNeuropathy TrialsRheumatoid Arthritis TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA